ENTA

Enanta Pharmaceuticals, Inc. News Headlines

$33.56
*  
0.18
 negative 
0.54%
Get ENTA Alerts
*Delayed - data as of Apr. 16, 2014 12:55 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENTA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Positive Data on AbbVie's HCV Program - Analyst Blog
4/14/2014 4:50:01 PM - Zacks.com

AbbVie To Present TURQUOISE-II Study Results At ILC
4/12/2014 1:42:00 AM - RTT News

Commit To Purchase Enanta Pharmaceuticals At $35, Earn 20.7% Annualized Using Options
3/10/2014 11:43:37 AM - BNK Invest

AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog
3/4/2014 6:10:01 PM - Zacks.com

A Picture Is Worth A Thousand Words: Implications From Sovaldi Treatment Trends
2/24/2014 3:24:00 PM - Seeking Alpha

Sector Update: Healthcare
2/13/2014 9:53:27 AM - MT Newswires

Sector Update: Healthcare Shares Fairly Flat; Acorda Q4 Earnings Top Street View
2/13/2014 9:52:59 AM - MT Newswires

Enanta (ENTA) Worth Watching: Stock Rises 13.4% - Tale of the Tape
2/3/2014 10:46:01 AM - Zacks.com

Enanta Announces Results From Four All-Oral, Interferon-Free, Phase 3 Studies
1/31/2014 8:23:00 AM - RTT News

A Glance At Our Winners And Losers In 2013
12/31/2013 5:22:00 PM - Seeking Alpha

Update on Amarin's Vascepa - Analyst Blog
12/27/2013 12:02:02 PM - Zacks.com

Sucampo Reports Data - Analyst Blog
12/26/2013 6:00:01 PM - Zacks.com

Update on NVO's Victoza - Analyst Blog
12/26/2013 1:10:01 PM - Zacks.com

EU Approves Actelion's Opsumit - Analyst Blog
12/24/2013 12:45:01 PM - Zacks.com

Enanta's Abbvie Partnership Is Going Places But It's Still Overvalued
12/16/2013 10:32:00 AM - Seeking Alpha

Strength Seen in Enanta Pharmaceuticals (ENTA): Stock Soars 28.6% - Tale of the Tape
12/11/2013 10:18:01 AM - Zacks.com

Good News for Apricus from Italy - Analyst Blog
11/26/2013 7:05:42 PM - Zacks.com

Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 6.2% - Tale of the Tape
11/26/2013 9:06:28 AM - Zacks.com

Continuation of ARIAD's Iclusig in EU - Analyst Blog
11/25/2013 6:00:01 PM - Zacks.com

Prescription for Profit - Zacks Industry Rank Analysis
11/19/2013 1:33:01 PM - Zacks.com

Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
10/18/2013 7:55:00 AM - Seeking Alpha

Near-Term Catalyst Could Double Enanta's Market Cap
10/17/2013 8:02:00 AM - Seeking Alpha

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
10/2/2013 9:30:01 AM - Zacks.com

Lock-Up Expiration Of West Corporation Shares Provides Shorting Opportunity
9/17/2013 6:56:00 AM - Seeking Alpha

Enanta Pharmaceeuticals Lock-up Expires September 17, Providing Shorting Opportunity
9/16/2013 5:25:00 AM - Seeking Alpha